Tag: Chris Parry
-
Do not adjust your TV sets – Heritage Cannabis (CANN.C) is a real business
New licenses, deals, products – that’s all good – but it’s not the nitty gritty stuff investors are looking for now. By “nitty-gritty” we mean – numbers. Four weeks ago, Heritage released its Q1, 2020 financials.
-
Isracann (IPOT.C) closes 3-year cannabis offtake deal in Israel
“We have achieved a partnership agreement with a farm operation that is constructed,” stated Isracann CEO, Darryl Jones, “it has already closed a major offtake agreement for the next three years. This accelerates our timeline to production and revenue.”
-
Vext Science (VEXT.C) seizes the opportunity in Arizona
“Medical marijuana dispensary owners who opted to expand into the adult-use market largely would do so in their existing physical locations,” stated The Phoenix New Times, “adding new staff and providing separate sales counters for medical and retail customers.”
-
The Good, the Bad & the Ugly; Trulieve Cannabis (TRUL.C), KushCo Holdings (KSHB.OTC) and Hexo (HEXO.NYSE) release financials
“Borrowing money and expanding hard in competition with MedMen (MMEN.C) is a two-edged sword,” explained Equity Guru’s Chris Parry, “In a strong market, you’re building far more value than you’re borrowing but, in a down market, you’re under extra pressure to keep things together when debts come due.”
-
Nextleaf (OILS.C) cuts a deal with an Ontario cannabis grower
OIL’s CEO, Paul Pedersen, believes the key to a strong sustainable cannabis extraction business is innovative technology protected by international patents.
-
World Class (PUMP.C) spikes 25% on agreement to purchase Pineapple Express
March, 2020 PED revenues increased 265% from those in January, 2020 – as the company’s operations ramp up to satisfy growing demand.
-
Hemptown USA CEO Eric Gripentrog gives a pre-IPO update
We are currently primarily focused on wholesale, selling bulk products. Quickly, we will be pivoting to the $16 billion dollar industry which breaks out between nutraceuticals, beauty aids, food and beverages.
-
World Class (PUMP.C)/Canntab JV receives cannabis extraction licences
World Class has begun to deliver the BOSS C02 Extraction Systems along with peripheral equipment to Canntab’s Markham facility. The facility is fully scalable – further BOSS systems are expected to be deployed as demand increases.
-
Vext Science (VEXT.C) ramps up Hemp/CBD operation in Kentucky
In VEXT’s latest financials we learned that “Gross Revenues increased 36% to USD $18.8 million for the nine months ended September 30, 2019 from USD $13.8 million for the nine months ended September 30, 2018.”